Suppr超能文献

用于肝脏疾病的干细胞移植的分子成像:监测、临床转化与诊疗一体化

Molecular Imaging of Stem Cell Transplantation for Liver Diseases: Monitoring, Clinical Translation, and Theranostics.

作者信息

Wang Ping, Petrella Francesco, Nicosia Luca, Bellomi Massimo, Rizzo Stefania

机构信息

Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.

Department of Thoracic Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.

出版信息

Stem Cells Int. 2016;2016:4058656. doi: 10.1155/2016/4058656. Epub 2016 Dec 14.

Abstract

Stem cell transplantation has been investigated to rescue experimental liver failure and is promising to offer an alternative therapy to liver transplantation for liver diseases treatment. Several clinical studies in this field have been carried out, but the therapeutic benefit of this treatment is still controversial. A major obstacle to developing stem cell therapies in clinic is being able to visualize the cells in vivo. Imaging modalities allow optimization of delivery, detecting cell survival and functionality by in vivo monitoring these transplanted graft cells. Moreover, theranostic imaging is a brand new field that utilizes nanometer-scale materials to glean diagnostic insight for simultaneous treatment, which is very promising to improve stem cell-based therapy for treatment of liver diseases. The aim of this review was to summarize the various imaging tools that have been explored with advanced molecular imaging probes. We also outline some recent progress of preclinical and clinical studies of liver stem cells transplantation. Finally, we discuss theranostic imaging for stem cells transplantation for liver dysfunction and future opportunities afforded by theranostic imaging.

摘要

干细胞移植已被用于研究挽救实验性肝衰竭,有望为肝脏疾病治疗提供一种替代肝移植的疗法。该领域已开展了多项临床研究,但这种治疗方法的疗效仍存在争议。临床开发干细胞疗法的一个主要障碍是能够在体内可视化细胞。成像方式可通过体内监测这些移植的移植细胞来优化递送、检测细胞存活和功能。此外,治疗诊断成像利用纳米级材料收集诊断信息以进行同步治疗,是一个全新的领域,对于改善基于干细胞的肝脏疾病治疗非常有前景。本综述的目的是总结已使用先进分子成像探针探索的各种成像工具。我们还概述了肝干细胞移植的临床前和临床研究的一些最新进展。最后,我们讨论用于肝功能障碍的干细胞移植的治疗诊断成像以及治疗诊断成像带来的未来机遇。

相似文献

4
Reactivity-Based Organic Theranostic Bioprobes.基于反应性的有机治疗诊断生物探针。
Acc Chem Res. 2019 Nov 19;52(11):3051-3063. doi: 10.1021/acs.accounts.9b00356. Epub 2019 Oct 7.
5
[Aiming for zero blindness].追求零失明
Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194.
7
Accomplishments and challenges in stem cell imaging in vivo.干细胞活体成像的成就与挑战。
Drug Discov Today. 2019 Feb;24(2):492-504. doi: 10.1016/j.drudis.2018.10.007. Epub 2018 Oct 17.
8
Emerging vistas in theranostic medicine.治疗医学的新视角。
Int J Pharm. 2019 Mar 10;558:29-42. doi: 10.1016/j.ijpharm.2018.12.068. Epub 2018 Dec 29.

引用本文的文献

6
Clinical Hepatocyte Transplantation: What Is Next?临床肝细胞移植:下一步是什么?
Curr Transplant Rep. 2017 Dec;4(4):280-289. doi: 10.1007/s40472-017-0165-6. Epub 2017 Oct 14.

本文引用的文献

8
Lost signature: progress and failures in in vivo tracking of implanted stem cells.丢失的信号:植入干细胞体内追踪的进展与失败
Appl Microbiol Biotechnol. 2015 Dec;99(23):9907-22. doi: 10.1007/s00253-015-6965-7. Epub 2015 Sep 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验